David J. Blanchard

Array ( [id] => 5880511 [patent_doc_number] => 20060029593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 10/938117 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16331 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029593.pdf [firstpage_image] =>[orig_patent_app_number] => 10938117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996276 [patent_doc_number] => 20050136054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 10/937949 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16050 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136054.pdf [firstpage_image] =>[orig_patent_app_number] => 10937949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103918 [patent_doc_number] => 20050106644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor' [patent_app_type] => utility [patent_app_number] => 10/936626 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 249 [patent_figures_cnt] => 249 [patent_no_of_words] => 82345 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10936626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045133 [patent_doc_number] => 20050249728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Anti-IGF-I receptor antibody' [patent_app_type] => utility [patent_app_number] => 10/932334 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20235 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249728.pdf [firstpage_image] =>[orig_patent_app_number] => 10932334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7154209 [patent_doc_number] => 20050026211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Compositions and methods relating to lung specific genes' [patent_app_type] => utility [patent_app_number] => 10/933058 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42842 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026211.pdf [firstpage_image] =>[orig_patent_app_number] => 10933058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666591 [patent_doc_number] => 20060171941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use' [patent_app_type] => utility [patent_app_number] => 10/570220 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24891 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171941.pdf [firstpage_image] =>[orig_patent_app_number] => 10570220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083237 [patent_doc_number] => 20050048617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Humanization of antibodies' [patent_app_type] => utility [patent_app_number] => 10/920899 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 75961 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048617.pdf [firstpage_image] =>[orig_patent_app_number] => 10920899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 795736 [patent_doc_number] => 07429652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Compositions and methods for generating chimeric heteromultimers' [patent_app_type] => utility [patent_app_number] => 10/911127 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23124 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429652.pdf [firstpage_image] =>[orig_patent_app_number] => 10911127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133252 [patent_doc_number] => 07696322 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Fusion antibodies' [patent_app_type] => utility [patent_app_number] => 10/900928 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 8 [patent_no_of_words] => 15343 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696322.pdf [firstpage_image] =>[orig_patent_app_number] => 10900928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083233 [patent_doc_number] => 20050048613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Secreted and transmebrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 10/899671 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 64622 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048613.pdf [firstpage_image] =>[orig_patent_app_number] => 10899671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050316 [patent_doc_number] => 20050186203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Anti-IGF-I receptor antibody' [patent_app_type] => utility [patent_app_number] => 10/897406 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20208 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186203.pdf [firstpage_image] =>[orig_patent_app_number] => 10897406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176206 [patent_doc_number] => 20050123549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'CA6 antigen-specific cytotoxic conjugate and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/895135 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 26171 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123549.pdf [firstpage_image] =>[orig_patent_app_number] => 10895135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 903703 [patent_doc_number] => 07335748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'RG1 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/895183 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17507 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335748.pdf [firstpage_image] =>[orig_patent_app_number] => 10895183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252232 [patent_doc_number] => 20050074821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors' [patent_app_type] => utility [patent_app_number] => 10/891658 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 35562 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074821.pdf [firstpage_image] =>[orig_patent_app_number] => 10891658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 520209 [patent_doc_number] => 07189825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 10/892597 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7020 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189825.pdf [firstpage_image] =>[orig_patent_app_number] => 10892597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 523490 [patent_doc_number] => 07186808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 10/891866 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7016 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186808.pdf [firstpage_image] =>[orig_patent_app_number] => 10891866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082680 [patent_doc_number] => 20050048060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Immunoconjugates' [patent_app_type] => utility [patent_app_number] => 10/885492 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7114 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048060.pdf [firstpage_image] =>[orig_patent_app_number] => 10885492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7328404 [patent_doc_number] => 20040253645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Method for reducing the immunogenicity of antibody variable domains' [patent_app_type] => new [patent_app_number] => 10/884133 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10828 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253645.pdf [firstpage_image] =>[orig_patent_app_number] => 10884133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5015779 [patent_doc_number] => 20070258987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Recombinant Anti-Cd30 Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/558811 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 42363 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258987.pdf [firstpage_image] =>[orig_patent_app_number] => 10558811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657129 [patent_doc_number] => 20080025990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Fully Human Antibodies Directed Against the Human Insulin-Like Growth Factor-1 Receptor' [patent_app_type] => utility [patent_app_number] => 10/555407 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 17885 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025990.pdf [firstpage_image] =>[orig_patent_app_number] => 10555407 [rel_patent_id] =>[rel_patent_doc_number] =>)